Cellceutix Corp.

Cellceutix Corp.

Sector: Pharmaceutical Preparations Region: MA, United States

: | OTC Markets: CTIX

Similar to: Sanofi, AstraZeneca Plc, Guerbet SA

Cellceutix Corp. is a clinical stage biotechnology company, which focuses on discovering small molecule drugs for hard to treat diseases, including drug-resistant cancers, psoriasis, autism and inflammatory disease. It flagship compound, Kevetrin, is an anti-cancer drug which has demonstrated the ability in pre-clinical studies to regulate the p53 pathway and attack cancers. The company was founded by Krishna Kumar Menon and Leo Ehrlich in June 2007 and is headquartered in Beverly, MA.

News & Analysis

You may also be interested in: